Search clinical trials for: Champix

Total 259 results

Sahlgrenska University Hospital, Sweden
Karolinska University Hospital; Malmö University

Completed

Does Varenicline Influence Alcohol Consumption in Alcohol Dependent Individuals?

Alcohol Dependence

Sweden
Pfizer

Withdrawn

A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With Schizophrenia

Schizophrenia
University of British Columbia
Provincial Health Services Authority

Withdrawn

Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)

Schizophrenia | Psychosis | Schizoaffective
Pfizer

Completed

Drug Use Investigation Of Varenicline (Regulatory Post Marketing Commitment Plan)

Smoking Cessation
Shaare Zedek Medical Center

Completed

Extended (6-Week) Varenicline Preloading: Does it Facilitate Smoking Reduction and Cessation?

Smoking Cessation

Israel
Pfizer

Completed

ASIA CHOICES CHampix (Varenicline) Observational Investigation in the CEssation of Smoking (ASIA CHOICES)

Smoking Cessation

Korea, Republic of, China, Philippines, India
Queen Mary University of London

Completed

Tailoring Varenicline to Individual Needs (TVIN Study) (TVIN)

Smoking Cessation | Tobacco Dependence

United Kingdom
Pfizer

Completed

Efficacy and Safety of Varenicline in Smokers With Cardiovascular Disease Who Wish to Quit Smoking

Smoking Cessation

United States, Korea, Republic of, Brazil, Australia, Canada, United Kingdom, France, Czech Republic, Germany, Greece, Netherlands, Denmark, Taiwan, Argentina, Mexico
Centre for Addiction and Mental Health
Pfizer

Completed

Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia

Smoking | Schizophrenia | Craving

Canada
Pfizer

Completed

Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease

Alzheimer's Disease

Korea, Republic of
Pfizer

Completed

A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking

Smoking

Japan
Pfizer

Completed

Post Marketing Surveillance Study of Champix in Smoking Cessation for Filipino Patients

Smoking Cessation
Pfizer

Completed

Assessing Neuropsychiatric Symptoms Including Depression, Anxiety, Irritability, and Suicidal Thoughts or Behavior in Subjects Quitting Smoking on Varenicline Tartrate or Placebo

Smoking Cessation

United States
Pfizer

Completed

Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).

Smoking Cessation

United States, France, Italy, Spain
Pfizer

Completed

Varenicline (Champix®) Special Investigation (Regulatory Post Marketing Commitment Plan)

Smoking Cessation
Centre for Addiction and Mental Health
Pfizer

Completed

Effect of Varenicline on Cognitive Function in Cigarette Smokers With Schizophrenia

Schizophrenia | Schizoaffective Disorder

Canada
Pfizer

Completed

Randomized Study Comparing the Efficacy and Safety of Varenicline Tartrate to Placebo in Smoking Cessation When Subjects Are Allowed to Set Their Own Quit Date

Smoking Cessation

United States, Czech Republic, Korea, Republic of, Brazil, Taiwan, Mexico, France, Italy, Hungary, Germany, Canada, China, Argentina, United Kingdom
Pfizer

Completed

Varenicline Observational Investigation In The Cessation of Smoking (CHOICES)

Smoking Cessation

Belgium, Hungary, Greece, Slovenia
Pfizer

Completed

Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression

Depression | Smoking Cessation

Spain, United States, Hungary, Germany, Bosnia and Herzegovina, Croatia, Romania, Russian Federation
Pfizer

Completed

Evaluation of Varenicline Safety, Tolerability, Pharmacokinetics and Pro-Cognitive Effects in Healthy Elderly Non-Smoking Subjects

Healthy | Non-Smoking

United States
Pfizer

Completed

A Phase I Study to Evaluate the Pharmacokinetics of Multiple Doses of Varenicline in Healthy Adolescent Smokers

Smoking Cessation

United States, United Kingdom
Mark Eisenberg
Sunnybrook Health Sciences Centre; Unity Health Toronto; Queen Elizabeth II Health...

Completed

Evaluation of Varenicline (Champix) in Smoking Cessation for Patients Post-Acute Coronary Syndrome (EVITA) Trial (EVITA)

Acute Coronary Syndrome

Canada
Pfizer

Completed

Post Marketing Surveillance Study To Observe Safety And Efficacy Of Champix® Tablets

Smoking Cessation
Maastricht University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development; Nabi...

Completed

Efficacy and Safety of NicVAX® Co-administered With Varenicline (Champix®)

Smoking Behavior | Smoking Lapse Behavior | Smoking Relapse Behavior

Netherlands
Centre for Addiction and Mental Health
Canadian Institutes of Health Research (CIHR); Canadian Tobacco Control Research...

Completed

Study of Varenicline (Champix) for Smoking Cessation/Reduction in Patients With Bipolar Disorder

Nicotine Dependence

Canada
The Queen Elizabeth Hospital

Completed

Smoking Termination Opportunity for inPatients (STOP)

Tobacco Use Disorder

Australia
Pfizer

Completed

Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder

Smoking Cessation

United States, Canada
Pfizer
Karolinska Institutet; University of Aarhus

Completed

Varenicline Pregnancy Cohort Study

Malformations
Sheba Medical Center
Hadassah Medical Organization; Barzilai Medical Center

Unknown

Early In-hospital Initiation of Pharmacotherapy for Smoking Cessation, Patients After ACS

Smoking Cessation | Acute Coronary Syndrome

Israel
Pfizer

Completed

A Single Dose Study Investigating the Absorption and Elimination as Well as the Tolerability of Varenicline Transdermal Delivery System (e.g., a Patch) as Compared to Oral Varenicline in Adult Smokers.

Smoking Cessation

United States
Pfizer

Completed

Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use

Tobacco Use Cessation

Norway, Sweden
Centre for Addiction and Mental Health
Ontario Lung Association

Completed

Varenicline in Drug Treatment (ViRT)

Smoking Cessation | Alcohol Abuse

Canada
Pfizer

Completed

Assessment of Safety and Efficacy of Varenicline in Patients That Wish to Stop Smoking

Smoking Cessation

Colombia, Mexico, Egypt, Jordan, Brazil, Costa Rica, Lebanon, Saudi Arabia, South Africa, United Arab Emirates, Venezuela
Mayo Clinic

Completed

Varenicline Treatment for Active Alcoholic Smokers

Smoking | Alcohol Dependence | Tobacco Dependence

United States
Centre for Addiction and Mental Health
Canadian Institutes of Health Research (CIHR)

Completed

Effect of Varenicline on Reactivity to Smoking and Drinking Cues

Alcohol Dependence | Tobacco Dependence

Canada
Vancouver Coastal Health
British Columbia Centre of Excellence for Women's Health

Unknown

Methadone Maintenance Treatment and Smoking Cessation (MMTASC)

Smoking

Canada
Mayo Clinic

Completed

Varenicline For Smokers In Recovery From Alcohol Dependence

Tobacco Abstinence

United States
Josep Maria Ramon Torrell, PhD

Completed

Clinical Trial to Evaluate the Efficacy of Smoking Cessation (COMBIVAR)

Smoking Cessation

Spain
University of Virginia
Johns Hopkins University; Virginia Commonwealth University

Unknown

Decision Navigation for Advanced Prostate Cancer Treatment Options Using mHealth

Decision Support Techniques

United States
Queen Mary University of London

Completed

Combination of Nicotine Replacement Therapy (NRT) and Varenicline to Increase Cessation of Tobacco (CONVICT Study) (CONVICT)

Smoking Cessation | Tobacco Dependence

United Kingdom
University of Bristol

Unknown

What Are the Effects of Varenicline Compared With Nicotine Replacement Therapy on Long Term Smoking Cessation and Clinically Important Outcomes?

Depression | Myocardial Infarction | Smoking Cessation | Cardiovascular Disease | Anxiety | Respiratory Disease
Memorial University of Newfoundland

Completed

Evaluating the Impact of a Champion on Implementation of the Back Skills Training (BeST) Program in Canada

Low Back Pain

Canada
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart Disease

Coronary Heart Disease

Canada
George Washington University
Rho, Inc.

Completed

Community Healthcare for Asthma Management and Prevention of Symptoms (CHAMPS)

Asthma

United States
Johns Hopkins University
National Heart, Lung, and Blood Institute (NHLBI); Baltimore City Health Department and other collaborators

Recruiting

Implementation of Asthma Community Home and School Management Program (Asthma CHAMPS)

Asthma in Children

United States
Wake Forest University Health Sciences
National Heart, Lung, and Blood Institute (NHLBI); University of South Carolina

Completed

Be a Champion! Comprehensive School Physical Activity Program (BAC!)

Motor Activity

United States
University of Maryland, Baltimore
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Terminated

Building Blocks for Healthy Preschoolers

Pediatric Obesity

United States
Brigham and Women's Hospital

Enrolling by invitation

The Brain Health Champion Study (BHC)

Mild Cognitive Impairment | Subjective Cognitive Decline | Dementia, Mild | At Risk for Cognitive Decline

United States
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Reducing Cardiovascular Disease by Combining Smoking Cessation Pharmacotherapy and Behavioural Counseling (RW)

Smoking Cessation | Psychiatric Illness

Canada
Lydia Furman
University Hospitals Cleveland Medical Center; Mt. Sinai Health Care Foundation

Completed

Prenatal Interventions to Promote Exclusive Breastfeeding

Health Behavior | Breastfeeding | Intention

United States

Search clinical trials for: Champix

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations